ACC 2026 – Dr Ann Marie Navar (UT Southwestern, US) delivers an expert breakdown of the most clinically impactful updates from the 2026 Dyslipidaemia Guidelines.

Join Dr Navar as she navigates the key recommendations shaping the future of lipid management, exploring what the updated guidance means for patient risk stratification, treatment targets, and real-world practice.

For more expert insights and late-breaking science from ACC 2026, visit the Late-breaking Science Video Collection.

Editor: Jordan Rance
Videographer: David Ben-Harosh, Dan Brent

Support: This is an independent video produced by Radcliffe Cardiology.